| Bioactivity | Benzoquinonium dibromide is a nicotinic acetylcholine receptors (nAChRs) antagonist, with an IC50 of 0.46 μM. Benzoquinonium dibromide can block neuromuscular and ganglionic transmission[1][2][3]. |
| Target | IC50: 0.46 μM (nAChRs) |
| Name | Benzoquinonium dibromide |
| Formula | C34H50Br2N4O2 |
| Molar Mass | 706.59 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Walker RJ, et, al. Physiological and pharmacological studies on annelid and nematode body wall muscle. Comp Biochem Physiol C Comp Pharmacol Toxicol. 1993 Sep;106(1):49-58. [2]. BOWMAN WC. The neuromuscular blocking action of benzoquinonium chloride in the cat and in the hen. Br J Pharmacol Chemother. 1958 Dec;13(4):521-30. [3]. Bowman WC, et, al. Neuromuscular blocking and ganglion blocking activities of some acetylcholine antagonists in the cat. J Pharm Pharmacol. 1972 Oct;24(10):762-72. |
Benzoquinonium dibromide
CAS: F: C34H50Br2N4O2 W: 706.59
Benzoquinonium dibromide is a nicotinic acetylcholine receptors (nAChRs) antagonist, with an IC50 of 0.46 μM. Benzoquin
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.